Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
28.01
-0.17 (-0.60%)
Official Closing Price
Updated: 7:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Pfizer
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
32
33
Next >
Immunization Intelligence Leader STChealth Hosts Historical 1st Vaccine Intelligence Manufacturer Summit, Connecting Leading Vaccine Manufacturers Pfizer & GSK
April 22, 2022
About STChealth STChealth’s mission is to eradicate vaccine preventable disease and empower individuals through our innovative technology and service solutions. We deliver on our mission through...
Via
PRUnderground
Haier Biomedical Participates in the UN COVAX Program to Help Fight the Pandemic in Bangladesh
April 21, 2022
Via
AB Newswire
Exposures
COVID-19
Pfizer Invites Shareholders to Attend Virtual-Only 2022 Annual Meeting of Shareholders on April 28
April 19, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer and BioNTech Announce Data Demonstrating High Immune Response Following a Booster Dose of their COVID-19 Vaccine in Children 5 Through 11 Years of Age
April 14, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer Names David M. Denton Chief Financial Officer
April 11, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates
April 07, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer and Alex Therapeutics to Provide Digital Solutions to German Patients
March 30, 2022
Berlin, Germany -- (SBWIRE) -- 03/30/2022 -- Digital therapies represent a huge growth area in German healthcare and have the potential to give many more patients access to a much broader selection of...
Via
SBWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Pfizer and BioNTech Receive Expanded U.S. Emergency Use Authorization for an Additional COVID-19 Vaccine Booster in Individuals Aged 50 Years and Older
March 29, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer Announces Positive Top-line Results from Yearlong Phase 3 Trial of Etrasimod in Ulcerative Colitis, Underscoring Best-in-Class Potential
March 29, 2022
From
Pfizer Inc.
Via
Business Wire
Acurx Pharmaceuticals Stands As Front-Line CDI Treatment Contender After Pfizer Misses Primary Endpoint In CDI Drug Trial (NASDAQ: ACXP)
March 28, 2022
Via
AB Newswire
Exposures
Product Safety
Race to Develop Universal ‘Variant-Proof’ Covid Vaccine Involves Several Players
March 24, 2022
FN Media Group Presents USA News Group News Commentary Vancouver, BC – March 24, 2022 – USA News Group – Whenever a new COVID-19 variant emergences, health authorities have had limited options to fight...
Via
FinancialNewsMedia
Exposures
COVID-19
Pfizer Granted FDA Breakthrough Therapy Designation for Respiratory Syncytial Virus Vaccine Candidate for the Prevention of RSV in Older Adults
March 24, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer Announces Positive Top-Line Results for Phase 3 Trial of Etrasimod in Ulcerative Colitis Patients
March 23, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer Invites Public to View and Listen to Webcast of May 3 Conference Call with Analysts
March 22, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer to Supply UNICEF up to 4 Million Treatment Courses of Novel COVID-19 Oral Treatment for Low- and Middle-Income Countries
March 22, 2022
From
Pfizer Inc.
Via
Business Wire
Vitiligo Market to Accelerate Substantially During the Forecast Period – DelveInsight | Key Companies – Amgen, Pfizer, Arcutis, Incyte Corp, and Sun Pharma Global FZE, and Others
March 10, 2022
Continue reading "Vitiligo Market to Accelerate Substantially During the Forecast Period – DelveInsight | Key Companies – Amgen, Pfizer, Arcutis, Incyte Corp, and Sun Pharma Global FZE, and Others"
Via
Get News
Acurx Pharmaceuticals Ibezapolstat Targets Front-Line Opportunity After Pfizer Fails To Reach CDI Trial Primary Endpoint (NASDAQ: ACXP)
March 07, 2022
Via
AB Newswire
NetworkNewsAudio – Flora Growth Corp. (NASDAQ: FLGC) Makes Mark in ‘Whirlwind’ of M&A Activity
March 04, 2022
Via
Investor Brand Network
Exposures
COVID-19
iShowcaseTV offers diverse original content in different genres
March 02, 2022
Via
AB Newswire
Renewable Energy Investment Market Size, Share, Trends, Industry Growth, and Forecast 2028 Top Key Players Spectrum, Roche, Pfizer, Novartis, Merck, Bayer, Healthcare Amgen
March 01, 2022
Renewable Energy Investment Market Size, Share, Growth, Industry Trends, Business Scope, Global Providers, COVID-19 Impact and Forecast 2028
Via
SBWire
Exposures
COVID-19
2022 Primed after 2021’s Record M&A Deals
March 01, 2022
Via
Investor Brand Network
Exposures
COVID-19
2022 Primed after 2021’s Record M&A Deals
March 01, 2022
Via
Investor Brand Network
Exposures
COVID-19
2022 Primed after 2021’s Record M&A Deals
March 01, 2022
NetworkNewsWire Editorial Coverage New York, NY – March 1, 2022 – Last year was a monumental year for merger and acquisition activity. Records worldwide weren’t just broken, they were smashed by M&A...
Via
FinancialNewsMedia
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
February 28, 2022
From
Pfizer Inc.
Via
Business Wire
mRNA Vaccines in Medical Engineering Cancer Treatment
February 24, 2022
New York, NY -- (SBWIRE) -- 02/24/2022 -- The same mRNA technology used in Pfizer-BioNTech's and Moderna's Covid vaccines is being trialed as a unique new medical engineering cancer treatment. The way...
Via
SBWire
Exposures
COVID-19
Pfizer Invests $68.5 Million in New Pharma R&D Facility
February 24, 2022
New York, NY -- (SBWIRE) -- 02/24/2022 -- Gene therapy is a vital field and one generating a wealth of R&D jobs in pharma today. Companies such as Pfizer are keen to capitalize on progress, as this...
Via
SBWire
Pfizer Invites Public to View and Listen to Webcast of Pfizer Keynote Presentation at Healthcare Conference
February 22, 2022
From
Pfizer Inc.
Via
Business Wire
U C, Inc., SMMR, Appoints New Board Member and CEO
February 21, 2022
U C, Inc., formerly named Symmetry Technologies, Inc. (OTC: SMMR), (the "Company"), announced today that, effective Feb. 14, 2022, it has appointed David Reckles as a new member to its Board of...
Via
Newswire.com
Topics
Stocks
Exposures
US Equities
Pfizer and OPKO’s Once-Weekly NGENLA™ (somatrogon) Injection Receives Marketing Authorization in European Union for Treatment of Pediatric Growth Hormone Deficiency
February 15, 2022
From
Pfizer Inc.
Via
Business Wire
European Medicines Agency Approves Pfizer’s 20-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease and Pneumonia in Adults
February 15, 2022
From
Pfizer Inc.
Via
Business Wire
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.